Language Therapy for Kids–MITA

• THE FIRST AND ONLY LANGUAGE THERAPY APPLICATION SUPPORTED BY CLINICAL DATA: In a 3-year clinical trial of 6,454 children with autism, language score in children who engaged with MITA has increased to levels, which were 120% higher than in children with similar initial evaluations. This difference was statistically significant (p=0.0001). See results at ClinicalTrials.gov/ct2/show/results/NCT04108290. • Received FDA breakthrough device designation (Q210093) • Based on US patent 20160210870